{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Progress in detecting breast cancer in its early stage is confronting more and more women with an agonizing problem: widespread disagreement in the medical profession on how to treat them. Because research has not yet yielded long-term answers about the best treatment for these breast tumors, women still reeling from the discovery that they have cancer must grapple with decisions that have no clear medical answer. Is a mastectomy to remove the breast needed, or would breast-sparing lumpectomy surgery, along with radiation, do the job? Is chemotherapy necessary to mop up cells that may have spread invisibly outside the breast?", "headline": {"main": "Quandary Created by Gain In Detecting Breast Cancer"}, "abstract": null, "print_page": "1", "word_count": 1851, "_id": "4fd1d2018eb7c8105d70cf9e", "snippet": "Progress in detecting breast cancer in its early stage is confronting more and more women with an agonizing problem: widespread disagreement in the medical profession on how to treat them.    Because research has not yet yielded long-term answers...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1991/07/21/us/quandary-created-by-gain-in-detecting-breast-cancer.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "LANGER, AMY"}, {"name": "glocations", "value": "SOUTHERN STATES (US)"}, {"name": "glocations", "value": "WESTERN STATES (US)"}, {"name": "glocations", "value": "NORTHWESTERN STATES (US)"}, {"name": "glocations", "value": "MIDWESTERN STATES (US)"}, {"name": "organizations", "value": "NATIONAL ASSN OF BREAST CANCER ORGANIZATIONS"}, {"name": "subject", "value": "BREAST"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "CHEMOTHERAPY"}, {"name": "subject", "value": "WOMEN"}, {"name": "subject", "value": "SURGERY AND SURGEONS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Elisabeth", "lastname": "ROSENTHAL"}], "original": "By ELISABETH ROSENTHAL"}, "document_type": "article", "pub_date": "1991-07-21T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "In a decision that sets new standards for drug approval, an advisory committee to the Food and Drug Administration recommended today that an AIDS drug be approved for marketing even though it has not been thoroughly tested in clinical trials. The drug, didanosine or dideoxyinosine, also known as DDI, is still being tested in clinical studies that would establish whether it is truly safe and effective. But because the need for new drugs to treat people with AIDS is so great, the committee decided that it could approve the drug on the basis of preliminary data that would ordinarily be considered indequate.", "headline": {"main": "U.S. Panel Backs Sale of Experimental AIDS Drug"}, "abstract": null, "print_page": "1", "word_count": 1160, "_id": "4fd1cfae8eb7c8105d708450", "snippet": "In a decision that sets new standards for drug approval, an advisory committee to the Food and Drug Administration recommended today that an AIDS drug be approved for marketing even though it has not been thoroughly tested in clinical trials.   The...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1991/07/20/us/us-panel-backs-sale-of-experimental-aids-drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "STANDARDS AND STANDARDIZATION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"}, {"name": "subject", "value": "DDI (DIDEOXYINOSINE) (DRUG)"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "NEW MODELS, DESIGN AND PRODUCTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "1991-07-20T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "In a highly unusual meeting, an advisory committee to the Food and Drug Administration today began deliberating on whether to approve for marketing a drug that has not been completely tested in normal clinical trials. The drug is an experimental AIDS remedy, and if it is allowed to go on the market it could establish new standards for the approval of drugs for life-threatening illnesses.", "headline": {"main": "U.S. Weighs Early Release of Experimental AIDS Drug"}, "abstract": null, "print_page": "14", "word_count": 936, "_id": "4fd1a4808eb7c8105d6bcce1", "snippet": "In a highly unusual meeting, an advisory committee to the Food and Drug Administration today began deliberating on whether to approve for marketing a drug that has not been completely tested in normal clinical trials.    The drug is an experimental...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1991/07/19/us/us-weighs-early-release-of-experimental-aids-drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "1991-07-19T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 3, "offset": 0, "time": 35}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}